The transporter 2, ATP-binding cassette, subfamily B (TAP2) is involved in the transport of antigenic peptides to HLA molecules. Coding TAP2 polymorphisms shows a strong association with type 1 diabetes, but it is not clear whether this association may be entirely due to linkage disequilibrium with HLA DR and DQ. Functionally, rat Tap2 nonsynonymous single-nucleotide polymorphisms (nsSNPs) confer differential selectivity for antigenic peptides, but this was not shown to be the case for human TAP2 nsSNPs. In the human, differential peptide selectivity is rather conferred by two splicing isoforms with alternative carboxy terminals. Here, we tested the hypothesis that alleles at the coding SNPs favor different splicing isoforms, thus determining peptide selectivity indirectly. This may be the basis for independent contribution to the type 1 diabetes association. In RNA from heterozygous lymphoblastoid lines, we measured the relative abundance of each SNP haplotype in each isoform. In isoform NM_000544, the G (Ala) allele at 665 Thr>Ala (rs241447) is more than twice as abundant as A (Thr) (GA ‫؍‬ 2.2 ؎ 0.4, P ‫؍‬ 1.5 ؋ 10 ؊4 ), while isoform NM_018833 is derived almost exclusively from chromosomes carrying A (AG ‫؍‬ 18.1 ؎ 5.6, P ‫؍‬ 2.04 ؋ 10 ؊7 ). In 889 Canadian children with type 1 diabetes, differential transmission of parental TAP2 alleles persisted (P ‫؍‬ 0.011) when analysis was confined to chromosomes carrying only DQ*02 alleles, which mark a conserved DR-DQ haplotype, thus eliminating most of the variation at DR-DQ. Thus, we present evidence of TAP2 association with type 1 diabetes that is independent of HLA DR-DQ and describe a plausible functional mechanism based on allele dependence of splicing into isoforms known to have differential peptide selectivities. Diabetes 56: 270 -275, 2007
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Functionally, the TAP1 and TAP2 genes, being involved in antigen presentation, are excellent candidates for association with autoimmune disease. The two gene products form a heterodimer that transports antigenic peptides from the cytoplasm into the endoplasmic reticulum (13) and is essential for loading antigen on HLA class I protein on the cell surface (14, 15) . Moreover, as TAP2 protein comes in direct contact with antigenic peptides, the possibility exists that its coding polymorphisms confer antigen selectivity, which complements that of the HLA molecules. This is consistent with an apparent excess of nsSNPs (four high-frequency nsSNPs, including 687 GlnϾTer that creates a stop codon truncating the carboxyl terminal by 17 amino acids). Like HLA (16, 17) , overabundance of coding TAP2 polymorphisms may reflect strong recent positive selection favoring heterozygosity and specificity for emerging pathogens.
In the rat, strong effects on peptide selectivity by coding TAP2 polymorphisms between strains have indeed been unequivocally demonstrated (18) . Although a similar effect by human polymorphisms has been claimed (19) , two thorough studies failed to find any evidence of it (20, 21) .
Interestingly, marked differences in antigenic selectivity have been reported (22) between the two known splicing isoforms of TAP2 (Fig. 1) . The first 10 exons are common to the two isoforms (NM_000544 and NM_018833), which differ by having a completely distinct 11th exon and, consequently, distinct carboxyl terminal ends and 3Ј un-translated regions. The presence of two splicing isoforms with distinct antigenic peptide selectivities has the advantage of expanding the range of peptides that can be processed, but, in terms of a functional role in the genetic association, this differential function can be important only if splicing is influenced by genetic variants in cis. The main purpose of this study was to determine whether this is the case. We also analyzed transmission of parental TAP2 and DQB1 haplotypes to children with type 1 diabetes, in our collection of Canadian families, as a first step in determining whether TAP2 polymorphisms mark type 1 diabetes risk that is independent of DR and DQ.
RESEARCH DESIGN AND METHODS
Genetic association analysis. Genomic DNA (gDNA) was obtained after informed consent from type 1 diabetes-affected subjects and their two parents (889 trios or 2,667 individuals after removing families with Mendelian discrepancies at multiple independent single-nucleotide polymorphisms [SNPs] ). The Research Ethics Board of the Montreal Children's Hospital and other participating centers approved the study. Ethnic backgrounds were of mixed European descent, with the largest single group being of Quebec FrenchCanadian origin (40% of the total collection). All patients were diagnosed as aged Ͻ18 years and required insulin treatment continuously from the time of diagnosis. SNP genotyping Six SNPs were genotyped by AcycloPrime-FP SNP Detection kit (PerkinElmer, Boston, MA). PCR primers and fluorescence polarization probes are available from the authors on request. PCR was performed in a Dual 384-Well GeneAmp PCR system 9700 in clear 384-well microplates (Axygen Scientific, Union City, CA). Unincorporated primers and dNTPs were removed according to the PE AcycloPrime PCR Clean-Up protocol. The final extension reaction was performed according to the PE AcycloPrime-FP protocol in Dual 384-well GeneAmp PCR system 9700 in black microplates (Axygen Scientific). Final detection of the SNP was done by the Criterion Analyst HT system (Molecular Devices, Sunnyvale, CA). All six SNPs had unambiguous clusters corresponding to the three genotypes. The average Mendelian error rate is Ͻ0.1%.
HLA-DQB1 exon 2 sequencing
The sequencing of the HLA-DQB1 exon 2 was based on the reported method (23) with a small modification. The exonic sense primer, 5Ј-CATGTGCTACT TCACCAACGG-3Ј, and antisense primer, 5Ј-GGCGACGACGCTCACCTC-3Ј, are the same as reported. Considering the polymorphic site in the intron 1/exon 2 primer, a degenerate sense primer spanning the intron 1/exon 2 border, 5Ј-ATTCCYCGCAGAGGATTTCG-3Ј, was adapted. To identify the HLA-DQB1 alleles from the sequencing results, Visual Basics for Applications scripts were written to align the sequence results with the allele sequences from the international ImMunoGeneTics project/HLA database (24) (http:// www.ebi.ac.uk/imgt/hla). This algorithm permits the identification of the HLA-DQB1*02 alleles from all other DQB1 alleles unambiguously. Of HLA-DQB1*02 alleles, the vast majority (99.8%) are *0201. This allele marks a remarkably conserved haplotype that removes most of the complexities of the DR-DQ region. Statistics Transmission disequilibrium test, LD analysis of SNPs were performed by Haploview software (available at www.broad.mit.edu/personal/jcbarret/ haploview) (25) . Haplotype association was tested by the TRANSMIT software (available at http://www-gene.cimr.cam.ac.uk/clayton/software/) (26) . By logistic regression, the odds ratio (OR) was estimated based on the methods described by Lohmueller et al. (27) . Allelic expression assay. RNA was prepared from lymphoblastoid cell lines immortalized from our type 1 diabetes family collection and used to determine the relative abundance of each SNP allele in RNA representing each of the two splicing isoforms by single-nucleotide primer extension. After RT-PCR with primers specific for each isoform ( Fig. 1) , an internal oligonucleotide probe immediately upstream of the polymorphic base was extended using ddNTPs corresponding to the two alleles and labeled with different fluorochromes (SnapShot kit; Applied Biosystems, Foster City, CA). Labeled extension products were visualized by capillary electrophoresis. Sequences of primers and probes are given in online appendix Table 1 (available at http://diabetes. diabetesjournals.org).
Allelic proportions in heterozygous gDNA PCR products were used to establish 1:1 stoichiometry and correct for different efficiencies of the two ddNTPs and fluorochromes. To assess the relative expression levels of each allele, the ratio of two alleles in the RT-PCR product was corrected by the average allelic proportion of the gDNA PCR product. Allelic proportions in RT-PCR products outside the 95% CI for gDNA were taken as showing allelic imbalance (AI), i.e., different representation of two alleles in the given isoform. The significance of allelic expression differences was tested by paired t test. AI association with a given SNP was assessed by 2 test (28) . Haplotypes of all five SNPs in all subjects used in the AI studies was unambiguously phased by genotyping family members.
RESULTS
Genetic association of TAP2 with type 1 diabetes. General-population allele frequencies of the SNPs examined are given in online appendix Table 2 . By the transmission disequilibrium test, we confirm previous observations that, except for the relatively rare SNP rs2228396, all the other five SNPs show a highly significant type 1 diabetes association ( Table 1 ). The five coding SNPs are in tight LD (Fig. 2) . Six haplotypes with frequency Ͼ1% composed of these five SNPs account for 99.5% of chromosomes in our type 1 diabetes nuclear family collection (Table 2 ). Each haplotype corresponds to one TAP2 type defined by the 12th HLA Workshop (29) . Dramatic type 1 diabetes association can be seen in the four common haplotypes with a frequency Ͼ5%, while type 1 diabetes association of the two more rare haplotypes cannot be excluded because of the low frequencies. Both individual SNP analysis and haplotype analysis suggest that two SNPs in tight LD (r 2 ϭ 0.990), 665 ThrϾAla (rs241447) and 687 GlnϾTer (rs241448), are the most highly associated. Their position in an alignment with the known TAP1 tertiary structure is shown in online appendix Fig. 1 . Because r 2 ϭ 0.99 between these SNPs, two of the four possible haplotypes accounted for Ͼ99% of chromosomes; AT was overtransmitted and GC undertransmitted.
For this reason, we proceeded to study the effect of these two haplotypes on splicing. Because of the high LD in the HLA region, dissecting this genetic effect from that of the adjacent DR-DQ locus requires regression analysis of large datasets. Evaluation of the functional significance of the polymorphisms involved may help focus such analysis. Genetically determined alternative splicing of TAP2. The relative abundance of each SNP haplotype in RT-PCR products specific for each isoform, in RNA from six unrelated heterozygous subjects, was determined by sinlge-nucleotide primer extension using the synonymous G/A SNP at 604 Gly (rs241441). The six subjects used for the allelic expression study were selected for being heterozygous for the two most highly type 1 diabetes-associated SNPs, 665 ThrϾAla and 687GlnϾTer. Because these SNPs do not exist in the transcribed region of NM_018833, we used the synonymous SNP rs241441 as the allelic expression marker. This SNP is known to be in complete LD with the other two (29) and unambiguously marks the haplotypes. In all six individuals, the G allele at this SNP marks the GC haplotype at 665 ThrϾAla and 687GlnϾTer, while the A marks AT (Table 3) . For isoform NM_000544, the results were also confirmed using 687 GlnϾTer, with nearly identical results. A representative electrophoresis profile is shown in Fig. 3 , and individual results detailed in Table 3 . At NM_000544, the average ratio of GC over AT is 2.23 Ϯ 0.44 (mean Ϯ SD) (P ϭ 1.55 ϫ 10 Ϫ4 ). Thus, in heterozygotes, approximately twice as much of that transcript is derived from the GC haplotype as from AT.
Conversely, transcript NM_018833 is almost exclusively derived from chromosomes containing the AT haplotype at the two associated SNPs (AT-to-GC ratio 18.06 Ϯ 5.58, P ϭ 2.04 ϫ 10
Ϫ7
). The effect is clearly due to these haplotypes ( 2 ϭ 8.3, P ϭ 0.004). Other common exonic SNPs are not involved, as differential splicing is clearly seen in individuals homozygous for them (Table 3) . Based on these results, it can be calculated that ϳ92% of mRNA *SNP alleles in the order of rs1800454-rs2228396-rs4148876-rs241447-rs241448. For example, the G-G-C-A-T haplotype means G allele of rs1800454, G allele of rs2228396, C allele of rs4148876, A allele of rs241447, and T allele of rs241448. †Nomenclature of the haplotype used by the 12th HLA Workshop.
TAP2 ALTERNATIVE SPLICING AND TYPE 1 DIABETES
carrying GC is spliced into NM_000544, while 75% of mRNA with AT gives NM_000544. Evidence of TAP2 contribution to type 1 diabetes association, independent of DR-DQ. As a first approach to dealing with the complexities of the HLA locus, we looked for the presence of a distortion in the transmission of haplotypes carrying each TAP2 allele, in cis to a DQB1*0201 allele. DQB1*0201 is common in the general population and much more so in individuals with type 1 diabetes. It is in tight LD with DRB1*0301, DRA*0102, and DQA1*0501 as part of a remarkably conserved, type 1 diabetes-predisposing haplotype (HLA-DR3) (30) . Thus, if only chromosomes carrying this haplotype are examined, distortion in the transmission of TAP2 alleles must be independent of DR-DQ. Table 4 shows the results of transmission analysis of those haplotypes. Of the 742 parental chromosomes carrying DQB1*0201, irrespective of TAP2 allele, 472 were transmitted to the offspring, whereas 270 were not (P ϭ 1.1 ϫ 10 Ϫ13 ), confirming the well-known predisposing effect of this allele. Most or all of this distortion is attributable to the common (because of LD) haplotype DQB1*0201-TAP2*Thr. The less common DQB1*02-rs241447*Ala is transmitted at a rate no different from the expected 50%. This is consistent with the protective effect of the Ala allele ( Table 1 ) that, in these haplotypes, appears to counterbalance the predisposing effect of DQB1*0201.The transmission ratios of the two haplotypes are significantly different ( 2 ϭ 6.5, P ϭ 0.011). Since the two haplotypes are largely identical at DR-DQ, the difference must be driven by the TAP2 polymorphism (or a genetic variant in LD with it).
DISCUSSION
It has long been known that the HLA locus on chromosome 6p21 accounts for approximately half of the familial clustering of type 1 diabetes (1). However the multiplicity of genes, their allelic complexity, and extensive LD at this locus have made it difficult to define the contribution of the various genes mapping to this area and the mechanisms involved. The strongest associations detected to date map to the DR-DQ region, but it is equally clear that the LD block containing these two crucial genes does not explain all of the linkage to the region (31) . Recent high-density SNP genotyping in the region revealed complex patterns of LD over an extended region of Ͼ4 Mb (20) and evidence of strong, recent positive selection (16, 17, 21) . Whether polymorphisms in any of a number of genes in the region may be independently contributing to type 1 diabetes risk can only be determined with regression analysis of densely genotyped large DNA sets. It is a reasonable expectation that such complex analysis may be greatly aided by functional clues.
Functionally, the TAP genes are prime candidates for association with autoimmune disease because they encode proteins that directly interact with antigenic epitopes. TAP2, specifically, has an unusually large number of nsSNPs with minor allele frequency Ͼ0.05. These may have been driven by the same evolutionary forces that have created the coding hypervariability in HLA molecules through positive selection of new mutations that broaden the spectrum of epitopes to accommodate emerging pathogens. Indeed, differential antigen selectivity has been reported with allelic TAP2 variants between strains of rats (18) , and there are also clear differential selectivities 
across species (32) . One report of differential selectivity among human protein-coding alleles (19) has not been substantiated, but differences between isoforms have been shown: The model peptide IYLGPFSPNVTL has a 30-fold lower affinity for isoform NM_018833 than for isoform NM_000544, while, conversely, TVDNKTRYE had 7-fold lower affinity for NM_000544 (22) . It is worth noting that TVDNKTRYE also shows marked selectivity for rat TAP2 alleles (33) .
Such isoform selectivity would be irrelevant to genetic association with the locus, unless alternative splicing generating each isoform is genetically determined. The data presented in this study clearly show that the diabetespredisposing haplotype favors formation of NM_018833. An alternative possibility for the AI seen in NM_000544 is nonsense-mediated decay of the allele creating a termination codon at position 687 (rs241448). However, nonsensemediated decay is typically seen when a premature termination codon occurs Ͼ50 -55 bp upstream from the last exon-exon junction (34, 35) , while rs241448 is well downstream of this position. In addition, nonsense-mediated decay cannot explain the AI seen in NM_018833, which does not contain this SNP.
In addition to demonstrating the functional effect of the TAP2 polymorphisms, we show that part of the previously known association of these variants with type 1 diabetes is clearly independent of DR-DQ, at least when in occurs on DQ*02 chromosomes. On the basis of our current genetic data, we cannot distinguish whether such independent contribution can be attributed to the polymorphisms responsible for this functional effect or due to LD with a remote variant of another gene in this genetically complex region. The two possibilities are, of course, not mutually exclusive, as multiple contributions to the linkage of type 1 diabetes to 6p21 are quite plausible. Conclusively dissecting genetic effects in this region of strong and extensive LD reqires the power of large sample sizes. It is to be hoped that the several thousand affected sibling pairs being assembled by the type 1 diabetes genetics consortium (http://t1dgc.org) will provide a conclusive answer, including confirmation of the finding reported here. Regardless, we propose that knowledge of the functional effects of key associated variants, such as the one we describe in this study, will be a crucial adjunct to genetic studies toward understanding the role of the locus in the pathogenesis of type 1 diabetes and, possibly, other autoimmune diseases. 
